✨ Free AI Report
Envoy Medical, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Envoy Medical, Inc.
Company Research

Envoy Medical, Inc.: Business Overview, Financials & Competitive Analysis

Envoy Medical, Inc. scores 6/10 on the AskCyborg Cyborg Score (Solid). Early-stage hearing implant innovator with differentiated fully-implanted technology approaching regulatory milestone, but capital-intensive R&D model and pre-commercial status create elevated risk. The company recently regained NASDAQ listing compliance after securing $30 million in an upsized public offering in February 2026. Envoy achieved full enrollment of its U.S. pivotal trial.

What is Envoy Medical, Inc.'s industry? Envoy Medical, Inc. (envoymedical.com) operates in Medical Devices - Hearing Implants & Audiology Solutions. AskCyborg classifies Envoy Medical, Inc. under Medical Devices - Hearing Implants & Audiology Solutions in its company registry.

Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. The company has pioneered fully implanted devices including the Esteem® active mi...

6/ 10Solid

Cyborg Score thesis

Early-stage hearing implant innovator with differentiated fully-implanted technology approaching regulatory milestone, but...

Read the full analyst-debate transcript →
Industry Medical Devices - Hearing Implants & Audiology Solutions
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest Envoy Medical, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Envoy Medical, Inc.

AskCyborg analysts argue the bull and bear cases for Envoy Medical, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Envoy Medical, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Envoy Medical, Inc. Overview

Pro stress-test →

Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. The company has pioneered fully implanted devices including the Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device.

Strategic Profile

Pro stress-test →

The Acclaim Cochlear Implant is designed to be the first fully implanted cochlear implant, featuring a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound. The device received FDA Breakthrough Device Designation in 2019. As of April 2026, the company completed enrollment of its pivotal clinical trial with all 56 patients having completed their activation visits.

Competitive Landscape

Pro stress-test →

Competitors are now openly discussing fully implanted plans, though Envoy believes its sensor technology and overall architecture provides a better solution than competitors pursuing total implantation. Primary competitors include traditional cochlear implant manufacturers (Cochlear, Advanced Bionics/Sonova, MED-EL) transitioning toward miniaturized and implanted solutions.

Industry Context

Envoy Medical, Inc. operates in Medical Devices - Hearing Implants & Audiology Solutions.

Key facts

Founded: 1995 · Headquarters: White Bear Lake, Minnesota, US

What the analysts stress-tested

The top findings that survived the multi-agent debate for Envoy Medical, Inc..

  • Clinical inflection point: Pivotal trial enrollment complete as of April 2026 with all 56 patients through activation visits, setting stage for regulatory submission
  • Capital raised: $30M upfront in February 2026 upsized offering with potential $48M additional tranches to fund commercialization
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • April 2026Completed enrollment of pivotal clinical trial with all 56 patients through activation visits
  • February 2026Received three new patents; regained NASDAQ listing compliance
  • +2 moreTrack every material event for Envoy Medical, Inc. as it happens. Explore monitoring →
Get alerted when Envoy Medical, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Cochlear CIMarket-leading external cochlear implants with miniaturization initiatives→Advanced BionicsEstablished external cochlear implant provider developing internal solutions→MED-ELGlobal cochlear implant manufacturer expanding implanted device portfolio→

Compare Envoy Medical, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Envoy Medical, Inc. operates in Medical Devices - Hearing Implants & Audiology Solutions. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Hearing Implants & Audiology Solutions research →
NEW · MCP server

Ask your AI assistant about Envoy Medical, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Envoy Medical, Inc. and its top competitor on Cyborg Score”
“What did Envoy Medical, Inc. do this quarter?”
“Is Envoy Medical, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Envoy Medical, Inc. do?+
Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. The company has pioneered fully implanted devices including the Esteem® active mi...
What is Envoy Medical, Inc.'s Cyborg Score?+
Envoy Medical, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Envoy Medical, Inc.'s main competitors?+
Named competitors include Cochlear CI, Advanced Bionics, MED-EL. The full competitive landscape is in the AskCyborg report.
How can I get the full Envoy Medical, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Envoy Medical, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Envoy Medical, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.